Travel-related hepatitis E: a two-decade GeoSentinel analysis.
HEV
epidemiology
geosentinel
hepatitis
travel
Journal
Journal of travel medicine
ISSN: 1708-8305
Titre abrégé: J Travel Med
Pays: England
ID NLM: 9434456
Informations de publication
Date de publication:
09 Nov 2020
09 Nov 2020
Historique:
received:
29
06
2020
revised:
27
07
2020
accepted:
06
08
2020
pubmed:
14
8
2020
medline:
29
7
2021
entrez:
14
8
2020
Statut:
ppublish
Résumé
Hepatitis E virus (HEV) is widely distributed worldwide and is endemic in developing countries. Travel-related HEV infection has been reported at national levels, but global data are missing. Moreover, the global availability of HEV diagnostic testing has not been explored so far. The aim of this study is to describe the epidemiology of HEV infections in returning travellers and availability of HEV diagnostic testing in the GeoSentinel surveillance network. This was a multicentre retrospective cross-sectional study. All confirmed and probable HEV travel-related infections reported in the GeoSentinel Network between 1999 and 2018 were evaluated. GeoSentinel sites were asked to complete a survey in 2018 to assess the availability and accessibility of HEV diagnostic procedures (i.e. serology and molecular tests) throughout the study period. Overall, 165 travel-related HEV infections were reported, mainly since 2010 (60%) and in tourists (50%). Travellers were exposed to hepatitis E in 27 countries; most travellers (62%) were exposed to HEV in South Asia. One patient was pregnant at the time of HEV infection and 14 had a concomitant gastrointestinal infection. No deaths were reported. In the 51% of patients with information available, there was no pre-travel consultation. Among 44 GeoSentinel sites that responded to the survey, 73% have access to HEV serology at a local level, while 55% could perform (at a local or central level) molecular diagnostics. Reported access to HEV diagnostic testing is suboptimal among sites that responded to the survey; this could negatively affect diagnosing HEV. Pre-travel consultations before travel to South Asia and other low-income and high-prevalence areas with a focus on food and water precautions could be helpful in preventing hepatitis E infection. Improved HEV diagnostic capacity should be implemented to prevent and correctly diagnose travel-related HEV infection.
Sections du résumé
BACKGROUND
BACKGROUND
Hepatitis E virus (HEV) is widely distributed worldwide and is endemic in developing countries. Travel-related HEV infection has been reported at national levels, but global data are missing. Moreover, the global availability of HEV diagnostic testing has not been explored so far. The aim of this study is to describe the epidemiology of HEV infections in returning travellers and availability of HEV diagnostic testing in the GeoSentinel surveillance network.
METHODS
METHODS
This was a multicentre retrospective cross-sectional study. All confirmed and probable HEV travel-related infections reported in the GeoSentinel Network between 1999 and 2018 were evaluated. GeoSentinel sites were asked to complete a survey in 2018 to assess the availability and accessibility of HEV diagnostic procedures (i.e. serology and molecular tests) throughout the study period.
RESULTS
RESULTS
Overall, 165 travel-related HEV infections were reported, mainly since 2010 (60%) and in tourists (50%). Travellers were exposed to hepatitis E in 27 countries; most travellers (62%) were exposed to HEV in South Asia. One patient was pregnant at the time of HEV infection and 14 had a concomitant gastrointestinal infection. No deaths were reported. In the 51% of patients with information available, there was no pre-travel consultation. Among 44 GeoSentinel sites that responded to the survey, 73% have access to HEV serology at a local level, while 55% could perform (at a local or central level) molecular diagnostics.
CONCLUSION
CONCLUSIONS
Reported access to HEV diagnostic testing is suboptimal among sites that responded to the survey; this could negatively affect diagnosing HEV. Pre-travel consultations before travel to South Asia and other low-income and high-prevalence areas with a focus on food and water precautions could be helpful in preventing hepatitis E infection. Improved HEV diagnostic capacity should be implemented to prevent and correctly diagnose travel-related HEV infection.
Identifiants
pubmed: 32789467
pii: 5891692
doi: 10.1093/jtm/taaa132
pmc: PMC9494553
mid: NIHMS1835348
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Intramural CDC HHS
ID : CC999999
Pays : United States
Organisme : NCEZID CDC HHS
ID : U50 CK000189
Pays : United States
Informations de copyright
© International Society of Travel Medicine 2020. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
Références
PLoS Negl Trop Dis. 2019 Jul 25;13(7):e0007453
pubmed: 31344038
Nat Rev Dis Primers. 2017 Nov 16;3:17086
pubmed: 29154369
J Hepatol. 2018 Jun;68(6):1256-1271
pubmed: 29609832
J Clin Virol. 2019 Nov;120:20-26
pubmed: 31536936
Epidemiol Infect. 2011 Aug;139(8):1145-50
pubmed: 20854712
Emerg Infect Dis. 2018 Jun;24(6):1055-1060
pubmed: 29774856
J Travel Med. 2019 Sep 2;26(6):
pubmed: 31407776
MMWR Surveill Summ. 2013 Jul 19;62:1-23
pubmed: 23863769
J Virol. 2017 Apr 13;91(9):
pubmed: 28202767
J Travel Med. 2016 Apr 11;23(4):
pubmed: 27069000
J Med Microbiol. 2018 Apr;67(4):466-480
pubmed: 29485390
J Infect Dis. 1997 Sep;176(3):763-6
pubmed: 9291328
Adv Exp Med Biol. 2016;948:89-112
pubmed: 27738981
Intervirology. 1983;20(1):23-31
pubmed: 6409836
J Travel Med. 2018 Jan 1;25(1):
pubmed: 30508133
Water Res. 2019 Mar 15;151:144-157
pubmed: 30594083
J Viral Hepat. 2019 Nov;26(11):1240-1248
pubmed: 31095813
J Travel Med. 2013 Jul-Aug;20(4):232-6
pubmed: 23809073
Med Microbiol Immunol. 2019 Dec;208(6):715-725
pubmed: 30903372
PLoS One. 2018 Jan 25;13(1):e0191798
pubmed: 29370254
Euro Surveill. 2019 Mar;24(10):
pubmed: 30862338
Am J Epidemiol. 2010 Oct 15;172(8):952-61
pubmed: 20801864
J Med Virol. 2004 Nov;74(3):419-24
pubmed: 15368508
Lancet. 2010 Sep 11;376(9744):895-902
pubmed: 20728932
Lancet. 2012 Jun 30;379(9835):2477-2488
pubmed: 22549046